尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Keeney Adam. Insider active across 1 company, notably BIOGEN INC.. Aggregated, 6 reports have been published. Activity tracked since 1 May 2024. The latest transaction was filed on 1 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Keeney Adam is Head of Corporate Development at BIOGEN INC. He has 6 filings in total, and the sampled recent filings cover the period from 2024-05-03 to 2026-05-05. In those recent filings, both the buy and sell amounts are 0 EUR, and the most frequent transaction nature is option exercise.